NOVOCART® 3D Autologous Chondrocyte Implant System U.S. Phase 3 Clinical Trial NOVOCART® 3D is considered an investigational product in the United States (meaning the product has not been approved by the FDA). NOVOCART® 3D has been used in a select few European countries since 2003 to treat more than 17,000 patients with damaged knee cartilage. Within the [...]